flavonoid/悪性腫瘍

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to flavonoid derivatives and, more particularly, to a flavonoid derivative or the pharmaceutically acceptable salt thereof that may be used in a pharmaceutical composition for preventing and treating cancer and

1. INTRODUCTION The present invention relates to compositions and methods for the prevention and treatment of oncogenic disorders, atherosclerosis and hypercholesterolemia, with citrus limonoids, flavonoids and/or tocotrienols. Limonoids are a group of chemically related triterpene derivatives found

BACKGROUND OF THE INVENTION Field of the Invention The invention generally relates to homogenous, synthetic, small molecules that selectively inhibit the growth of cancer stem cells, for example colorectal cancer stem cells, and prevent replacement or recurrence of the observed cancer. Background of

BACKGROUND OF THE INVENTION Throughout this application, various publications are referenced by Arabic numerals within parentheses. Full citations for these publications may be found at the end of the specification immediately preceding the claims. The disclosures of these publications in their

CROSS REFERENCE TO RELATED APPLICATION This application claims the benefit of Korean Patent Application No. 10-2014-0111413, filed Aug. 26, 2014. The Korean application is incorporated herein in its entirety. BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a

FIELD OF THE INVENTION The invention relates to novel alkyne-, azide- and triazole-containing flavonoid compounds, methods of preparing the same, and use of these compounds for reducing multidrug resistance caused by overexpression of ABC transporters. This invention relates to a new method of

FIELD OF THE INVENTION The invention relates to novel alkyne-, azide- and triazole-containing flavonoid compounds, methods of preparing the same, and use of these compounds for reducing multidrug resistance caused by overexpression of ABC transporters. This invention relates to a new method of

CROSS REFERENCE TO RELATED APPLICATIONS This application is the national phase entry of International Application No. PCT/CN2016/096711, filed on Aug. 25, 2016, which is based upon and claims priority to Chinese Patent Application No. CN201510404716.2, filed on Jul. 10, 2015, the entire contents of

FIELD OF THE INVENTION The present invention relates to a composition for treating cancer cells and a preparation method therefor, and more particularly to the composition comprising extracts of Thelypteris torresiana and the preparation method therefor. BACKGROUND OF THE INVENTION Recently many

FIELD OF THE INVENTION The present invention relates to a composition for treating cancer cells and a preparation method therefor, and more particularly to the composition comprising extracts of Thelypteris torresiana and the preparation method therefor. BACKGROUND OF THE INVENTION Recently many

FIELD OF THE INVENTION The present invention relates to a composition for treating cancer cells and a preparation method therefor, and more particularly to the composition comprising extracts of Thelypteris torresiana and the preparation method therefor. BACKGROUND OF THE INVENTION Recently many

FIELD OF THE INVENTION The present invention relates to a composition for treating cancer cells and a preparation method therefor, and more particularly to the composition comprising extracts of Thelypteris torresiana and the preparation method therefor. BACKGROUND OF THE INVENTION Recently many

FIELD OF THE INVENTION The present invention discloses a novel method to isolate a natural flavonoid; inoscavin A indicated in formula 1, from mushroom F. fastuosus, having promising antiprolifertive activity on rhabdomyosarcoma and thereby communicates its application to use it as a medicinal

I. FIELD OF THE INVENTION This invention relates to methods of using phenylacetic acid and its pharmaceutically acceptable derivatives to treat and prevent pathologies and to modulate cellular activities. In particular, this invention relates to A) phenylacetate and its derivatives in cancer

I. FIELD OF THE INVENTION This invention relates to methods of using phenylacetic acid and its pharmaceutically acceptable derivatives to treat and prevent pathologies and to modulate cellular activities. In particular, this invention relates to A) phenylacetate and its derivatives in cancer